DC Studios has a new contender for a commercial breakthrough. “Clayface,” the horror-thriller starring Tom Rhys Harries as the doomed Gotham performer Matt Hagen, opened in theaters on October 19, 2026, and arrives at a moment when the studio’s slate badly needs a winner. The film, directed by James Watkins and running 109 minutes, is positioned as a darker, more intimate bet than the franchise spectacles that typically dominate the release calendar, and early reception suggests the gamble may be paying off.

According to TMDb, the film currently holds a 7.4 out of 10 rating from users. That figure is not a box-office tally, but it points to a warm response from viewers who have seen it - a useful signal for a studio hoping word of mouth can carry a mid-budget genre title through a crowded October.

A Hollywood Story With a Body-Horror Core

“Clayface” follows Matt Hagen’s rise from Gotham street kid to Hollywood leading man, a trajectory that collapses when a local crime boss’s actions leave him horribly disfigured. Abandoned by his own team and with nothing left to lose, Hagen pursues an experimental treatment that restores him to his former self - and then begins to erode his grip on reality. What follows, per the film’s official synopsis, is a descent into an all-consuming quest for revenge.

The setup lets Watkins blend the trappings of a show-business cautionary tale with science-fiction and horror elements, a combination that distinguishes the project from standard superhero-adjacent fare. Harries leads the cast as Hagen and his transformed alter ego. Naomi Ackie plays Caitlyn Corr, with Eddie Marsan as Frank Fitzpatrick, Max Minghella as John Borrelli, David Dencik as Marcos Jabo, Francesca Corney as Rosie, Ruby Sear as Theresa and Wil Coban as Bones rounding out the ensemble.

A Mid-Budget Test for DC Studios

The film’s commercial importance extends beyond its own ledger. DC Studios has spent recent years recalibrating its output, and a genre piece built around a single tortured protagonist offers a lower-risk path to a hit than a tentpole dependent on worldwide spectacle. “Clayface” carries a runtime well under two hours, a contained premise and a recognizable but not oversized cast - all factors that can improve a film’s odds of profitability if audiences show up.

The 7.4 audience score on TMDb gives the studio something to work with in the coming weeks. For a title like this, sustained interest often depends less on opening-weekend noise than on whether viewers recommend it to friends. A well-liked horror-tinged thriller can hold screens longer than its opening numbers might suggest.

“You Can See Everything” Keeps Its Footing

Meanwhile, “You Can See Everything” remains strong on the release charts, according to the available information. The film’s continued performance gives the marketplace a second conversation piece and sets up an interesting contrast: one title leaning on established appetite, the other asking audiences to take a chance on a darker, less familiar property. How the two films divide attention in the weeks ahead will say a lot about what kind of material is drawing crowds this fall.

For DC Studios, the more immediate question is whether “Clayface” can convert its favorable reception into the kind of durable turnout that turns a good opening into a genuine win. The studio has not been short of ambitious swings; it has been shorter on unambiguous successes. A strong run here would not only validate the decision to hand a major character to a horror specialist like Watkins, but also encourage further experiments in tone and scale.

What Comes Next

The film’s release date, October 19, places it squarely in the pre-Halloween window, when horror-leaning titles traditionally find receptive audiences. Whether “Clayface” can capitalize on that seasonal advantage - and whether its 7.4 rating climbs or slips as more viewers weigh in - will be the story to watch. For now, DC Studios has a film in theaters, a lead performance generating discussion and a premise that stands apart from the usual franchise template.

That may be enough to count as progress. In a year when the studio is looking for signs of momentum, a well-received, modestly scaled thriller with a clear identity is a meaningful data point. “Clayface” now has the chance to prove that the interest it has generated can translate into the one result DC Studios needs most: a box-office win.

Source: Hollywood Reporter